Discover recent advancements in near-infrared fluorescence imaging that have revolutionised lymph node tracing in cancers ...
Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...
Peering into the body to find and diagnose cancer is all about spotting patterns. Radiologists use x-rays and magnetic ...
This blog explores the benefits of applying Large Language Models to extract information from pathology reports, allowing us to curate bespoke ...
Using multiparametric MRI (mpMRI) before surgery reduced time to correct treatment by 45 days for patients with muscle invasive bladder cancer. The imaging procedure was successful for over 92% of ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...
A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...
including cancer pathology, cancer genetics, cell signaling, control of cell growth, tumor apoptosis, cancer pharmacology, cancer therapeutics, stem cell biology, cancer imaging, tumor immunology and ...
The high expression levels of HDACs observed particularly in high grade urothelial bladder cancer clearly warrant subsequent studies on the potential use of HDAC inhibitors as a novel therapeutic ...
The gold standard for identifying histological variants in bladder cancer relies on the pathologist’s judgment of the pathology specimen (12, 13). However, most of these specimens are obtained through ...
1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China. 2Key Laboratory, Department of Urology and Andrology, The Affiliated Hospital of Qingdao University, Qingdao, ...
Bladder cancer is one of the most common malignant tumors of the urinary system globally. It is also one of the most expensive cancers to manage, due to the need for extensive treatment and follow-ups ...